Study to evaluate the effect of an investigational drug for reducing
the risk of major cardiovascular events in abdominally obese patients
with multiple risk factors. Subjects must be 55 years of age with abdominal
obesity and additional risk factors. Please contact us at 630.734.3485
for additional information if you feel you may qualify.
view all clinical trials